Bonothyrk N20 – parathyroid gland

A complex of peptide fractions obtained from the parathyroid glands of young animals. The isolated peptides have a selective effect on the cells of parathyroid glands, normalize their metabolism, increase their functional activity. In clinical studies the efficacy of “Bonotirk” was established for restoration of functional activity of parathyroid glands in disorders of various genesis, including hyperparathyroidism, including osteoporosis, demineralization of bone tissue, urolithiasis, muscle weakness as well as in hypoparathyroidism, including hypocalcemia, muscle cramps, muscle numbness.

Recommended:
– in osteoporosis
– in bone demineralization
– in urolithiasis
– in muscle weakness due to parathyroid gland hyperplasia– with muscle cramps, muscle numbness caused by hypocalcemia

Product composition
Composition (per 1 capsule): A-21 peptide complex (parathyroid peptides), microcrystalline cellulose (E460, anti-caking agent), gelatin (encapsulation agent), beet sugar (binding filler), lactose (moisture-holding filler), starch (stabilizer), tween-80 (emulsifier), titanium dioxide (E171, capsule coloring).

A daily dose contains: (2 capsules), 20 mg of peptide complex A-21.

How to use
Adults: 1-2 capsules 1-2 times daily with meals. Duration of use – 1 month.

Brand form: 20 capsules of 0.2 g